167 related articles for article (PubMed ID: 11290551)
21. Immunohistochemical localization of FAP-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues.
Lee SH; Shin MS; Park WS; Kim SY; Kim HS; Lee JH; Han SY; Lee HK; Park JY; Oh RR; Jang JJ; Lee JY; Yoo NJ
APMIS; 1999 Dec; 107(12):1101-8. PubMed ID: 10660140
[TBL] [Abstract][Full Text] [Related]
22. Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production.
Yamada Y; Sugahara K; Tsuruda K; Nohda K; Hata T; Maeda T; Honda M; Tawara M; Hayashibara T; Joh T; Tomonaga M; Miyazaki Y; Kamihira S
Cancer Lett; 1999 Dec; 147(1-2):215-9. PubMed ID: 10660109
[TBL] [Abstract][Full Text] [Related]
23. The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis.
Yanagisawa J; Takahashi M; Kanki H; Yano-Yanagisawa H; Tazunoki T; Sawa E; Nishitoba T; Kamishohara M; Kobayashi E; Kataoka S; Sato T
J Biol Chem; 1997 Mar; 272(13):8539-45. PubMed ID: 9079683
[TBL] [Abstract][Full Text] [Related]
24. Protein-tyrosine phosphatase PTPL1/FAP-1 triggers apoptosis in human breast cancer cells.
Bompard G; Puech C; Prébois C; Vignon F; Freiss G
J Biol Chem; 2002 Dec; 277(49):47861-9. PubMed ID: 12354757
[TBL] [Abstract][Full Text] [Related]
25. [Development of anti cancer drugs targeted on Fas-mediated apoptosis signal].
Takahashi M; Kataoka S
Gan To Kagaku Ryoho; 1997 Jan; 24(2):222-8. PubMed ID: 9030235
[TBL] [Abstract][Full Text] [Related]
26. mRNA expression of Fas receptor (CD95)-associated proteins (Fas-associated phosphatase-1/FAP-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/RIP) in human leukaemia/lymphoma cell lines.
Komada Y; Inaba H; Zhou YW; Zhang XL; Tanaka S; Azuma E; Sakurai M
Br J Haematol; 1997 Nov; 99(2):325-30. PubMed ID: 9375749
[TBL] [Abstract][Full Text] [Related]
27. Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma.
Denkert C; Schmitt WD; Berger S; Reles A; Pest S; Siegert A; Lichtenegger W; Dietel M; Hauptmann S
Int J Cancer; 2002 Dec; 102(5):507-13. PubMed ID: 12432554
[TBL] [Abstract][Full Text] [Related]
28. Structural modification of Fas C-terminal tripeptide and its effects on the inhibitory activity of Fas/FAP-1 binding.
Sawa E; Takahashi M; Kamishohara M; Tazunoki T; Kimura K; Arai M; Miyazaki T; Kataoka S; Nishitoba T
J Med Chem; 1999 Aug; 42(17):3289-99. PubMed ID: 10464015
[TBL] [Abstract][Full Text] [Related]
29. Opposite roles of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosis.
Ivanov VN; Ronai Z; Hei TK
J Biol Chem; 2006 Jan; 281(3):1840-52. PubMed ID: 16306044
[TBL] [Abstract][Full Text] [Related]
30. FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis.
Ungefroren H; Kruse ML; Trauzold A; Roeschmann S; Roeder C; Arlt A; Henne-Bruns D; Kalthoff H
J Cell Sci; 2001 Aug; 114(Pt 15):2735-46. PubMed ID: 11683408
[TBL] [Abstract][Full Text] [Related]
31. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.
Lee SH; Shin MS; Lee HS; Bae JH; Lee HK; Kim HS; Kim SY; Jang JJ; Joo M; Kang YK; Park WS; Park JY; Oh RR; Han SY; Lee JH; Kim SH; Lee JY; Yoo NJ
Hum Pathol; 2001 Mar; 32(3):250-6. PubMed ID: 11274632
[TBL] [Abstract][Full Text] [Related]
32. Fas-associated phosphatase-1 promotes Fas-mediated apoptosis in human colon cancer cells: novel function of FAP-1.
Miyazaki T; Atarashi Y; Yasumura S; Minatoya I; Ogawa K; Iwamoto M; Minemura M; Shimizu Y; Sato TA; Watanabe A; Sugiyama T
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):84-91. PubMed ID: 16706817
[TBL] [Abstract][Full Text] [Related]
33. Ionizing radiation suppresses FAP-1 mRNA level in A549 cells via p53 activation.
Yamada T; Maruyama M; Fujita T; Miyabayashi K; Shinoda C; Kawagishi Y; Fujishita T; Hayashi R; Miwa T; Arai N; Matsui S; Sugiyama E; Kobayashi M
FEBS Lett; 2006 Aug; 580(18):4387-91. PubMed ID: 16844116
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.
Choi YJ; Baranowska-Daca E; Nguyen V; Koji T; Ballantyne CM; Sheikh-Hamad D; Suki WN; Truong LD
Kidney Int; 2000 Oct; 58(4):1481-91. PubMed ID: 11012883
[TBL] [Abstract][Full Text] [Related]
35. No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphatase-1 in Fas-mediated apoptosis.
Cuppen E; Nagata S; Wieringa B; Hendriks W
J Biol Chem; 1997 Nov; 272(48):30215-20. PubMed ID: 9374505
[TBL] [Abstract][Full Text] [Related]
36. Primary ovarian cancer cultures are resistant to Fas-mediated apoptosis.
Baldwin RL; Tran H; Karlan BY
Gynecol Oncol; 1999 Aug; 74(2):265-71. PubMed ID: 10419743
[TBL] [Abstract][Full Text] [Related]
37. Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells.
Vondrácek J; Sheard MA; Krejcí P; Minksová K; Hofmanová J; Kozubík A
J Leukoc Biol; 2001 May; 69(5):794-802. PubMed ID: 11358989
[TBL] [Abstract][Full Text] [Related]
38. Fas-mediated apoptosis in human prostatic carcinoma cell lines.
Rokhlin OW; Bishop GA; Hostager BS; Waldschmidt TJ; Sidorenko SP; Pavloff N; Kiefer MC; Umansky SR; Glover RA; Cohen MB
Cancer Res; 1997 May; 57(9):1758-68. PubMed ID: 9135020
[TBL] [Abstract][Full Text] [Related]
39. Expression of genes that regulate Fas signalling and Fas-mediated apoptosis in colon carcinoma cells.
Tillman DM; Harwood FG; Gibson AA; Houghton JA
Cell Death Differ; 1998 May; 5(5):450-7. PubMed ID: 10200495
[TBL] [Abstract][Full Text] [Related]
40. Human pancreatic cancer cells disable function of Fas receptors at several levels in Fas signal transduction pathway.
Elnemr A; Ohta T; Yachie A; Kayahara M; Kitagawa H; Fujimura T; Ninomiya I; Fushida S; Nishimura GI; Shimizu K; Miwa K
Int J Oncol; 2001 Feb; 18(2):311-6. PubMed ID: 11172597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
